Rosalind Kalb from the National Multiple Sclerosis Society: Treating Advanced Disease in Multiple Sclerosis
JUNE 03, 2016
Defining what advanced disease means in multiple sclerosis is a topic open for discussion. Deciding a course of treatment after that determination is another challenge in overall patient care.
Rosalind Kalb, PhD, from the National Multiple Sclerosis Society discussed this issue during the annual meeeting of the Consortium of Multiple Sclerosis Centers in National Harbor, Maryland. Kalb said that while there may be disagreement on what qualifies as advanced disease there is no question that patients in this classification need a specialized level of care through the later stages of their disease.